Pulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPD

Abstract

Airway obstruction and parenchymal destruction underlie phenotype and severity in chronic obstructive pulmonary disease (COPD). We aimed to predict, by clinical and pulmonary function data, the predominant type and severity of pathological changes quantitatively assessed by computed tomography (CT).Airway wall thickness (AWT-Pi10) and percentage of lung area with X-ray attenuation values ,-950 HU (%LAA-950) were measured in 100 (learning set) out of 473 COPD outpatients undergoing clinical and functional evaluation. Original CT measurements were translated by principal component analysis onto a plane with the novel coordinates CT1 and CT2, depending on the difference (prevalent mechanism of airflow limitation) and on the sum (severity) of AWT-Pi10 and %LAA-950, respectively. CT1 and CT2, estimated in the learning set by cross-validated models of clinical and functional variables, were used to classify 373 patients in the testing set.A model based on diffusing capacity of the lung for carbon monoxide, total lung capacity and purulent sputum predicted CT1 (r50.64; p,0.01). A model based on forced expiratory volume in 1 s/vital capacity, functional residual capacity and purulent sputum predicted CT2 (r50.77; p,0.01). Classification of patients in the testing set obtained by model-predicted CT1 and CT2 reflected, according to correlations with clinical and functional variables, both COPD phenotype and severity.Multivariate models based on pulmonary function variables and sputum purulence classify patients according to overall severity and predominant phenotype of COPD as assessed quantitatively by CT. @ERSpublications Pulmonary function and sputum purulence models classify COPD patients by severity and phenotype as quantified by CT

Adrenomedullin refines mortality prediction by the BODE index in COPD: the “BODE-A” index

“…according to the presence and severity of flogistic process or distinctive comorbidities. Within this context, whether proadrenomedullin could be used to differentiate between the two main mechanisms of airflow obstruction in COPD, namely conductive airway inflammation and a parenchymal disruption [51,52], perhaps giving the degree of arterial hypoxaemia, deserves further evaluation.…”

Fat-Free Mass Index for Evaluating the Nutritional Status and Disease Severity in COPD

“…24 Both scans were performed in a supine position using a 256-slice CT scanner (Brilliance iCT, Philips, Eindhoven, Netherlands). 24 The percentage of low-attenuation area was calculated using a previously reported method, with Ϫ960 HU as the cut-off level. The dimensions of the right apical segmental bronchus were measured as described previously, and the percentage of wall area was used in the analyses.…”

“…The dimensions of the right apical segmental bronchus were measured as described previously, and the percentage of wall area was used in the analyses. 24 …”

Symptomatic, frail, elderly patients: the urgent need for comprehensive assessment and management

“…Studies including measurement of small airway function, though inconclusive, have been used in an attempt to identify more subtle changes in airway function, without success [5,13]. Novel imaging methods [8,9] and biomarker profiles [14,15] show promise, but we are not there yet. Consequently, a suitable alternative to spirometry has yet to be discovered.…”

“…Research focused on the respiratory system has also brought about the development of physiological and imaging methods to assess peripheral airways and lung parenchyma [7][8][9], and has furthered understanding of the natural history of COPD, particularly the progressive decline in lung function and its modulation by pharmacological intervention [10]. Thanks to the results of these studies, we now know much more about COPD, about the potential and limitations of screening [11] and early diagnosis based on spirometry, and about interventions in early asymptomatic and newly discovered COPD.…”